On November 7, 2018 Forbius, a clinical stage company developing biotherapeutics targeting EGFR and TGF-β pathways, reported that Ilia Tikhomirov, CEO of Forbius, will be presenting at two upcoming investor conferences in November (Press release, Forbius, NOV 7, 2018, View Source [SID1234531667]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details for the presentations:

Event: Jefferies 2018 London Healthcare Conference

Date: Wednesday, November 14, 2018

Time: 10:40 a.m. GMT

Event: Evercore ISI Healthcare Conference

Date: Wednesday, November 28, 2018

Time: 2:20 p.m. EST